Not all melanomas are created equal: a review and call for more research into nodular melanoma
暂无分享,去创建一个
A. Lallas | R. Scolyer | C. Garbe | G. Pellacani | D. Whiteman | J. Grob | A. Geller | A. Stratigos | C. Dessinioti | J. Kelly | R. Rawson
[1] C. Longo,et al. In vivo microscopic features of nodular melanomas: dermoscopy, confocal microscopy, and histopathologic correlates. , 2008, Archives of dermatology.
[2] Josep Malvehy,et al. Historical, clinical, and dermoscopic characteristics of thin nodular melanoma. , 2010, Archives of dermatology.
[3] Victor G Prieto,et al. Protocol for the examination of specimens from patients with melanoma of the skin. , 2009, Archives of pathology & laboratory medicine.
[4] Stephen W Dusza,et al. Melanoma Thickness and Survival Trends in the United States, 1989 to 2009. , 2016, Journal of the National Cancer Institute.
[5] J. Aitken,et al. Population-based 20-year survival among people diagnosed with thin melanomas in Queensland, Australia. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] I. Zalaudek,et al. Improving the early diagnosis of early nodular melanoma: can we do better? , 2018, Expert review of anticancer therapy.
[7] P. Carli,et al. Dermatologist detection and skin self-examination are associated with thinner melanomas: results from a survey of the Italian Multidisciplinary Group on Melanoma. , 2003, Archives of dermatology.
[8] J. Choi,et al. Frequencies of BRAF and NRAS mutations are different in histological types and sites of origin of cutaneous melanoma: a meta‐analysis , 2011, The British journal of dermatology.
[9] Y. Fujisawa,et al. Clinical and histopathological characteristics and survival analysis of 4594 Japanese patients with melanoma , 2019, Cancer medicine.
[10] H. Cabo,et al. Dermatoscopic features of thin (≤2 mm Breslow thickness) vs. thick (>2 mm Breslow thickness) nodular melanoma and predictors of nodular melanoma versus nodular non‐melanoma tumours: a multicentric collaborative study by the International Dermoscopy Society , 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.
[11] B. Bastian,et al. From melanocytes to melanomas , 2016, Nature Reviews Cancer.
[12] J. Adler. Nodular melanoma. , 1979, The American Journal of dermatopathology.
[13] J. Kelly. Nodular melanoma: how current approaches to early detection are failing. , 2005, Journal of Drugs in Dermatology.
[14] S. Swetter,et al. Factors related to the presentation of thin and thick nodular melanoma from a population‐based cancer registry in Queensland Australia , 2009, Cancer.
[15] D. Elder,et al. The 2018 World Health Organization Classification of Cutaneous, Mucosal, and Uveal Melanoma: Detailed Analysis of 9 Distinct Subtypes Defined by Their Evolutionary Pathway. , 2020, Archives of pathology & laboratory medicine.
[16] I Zalaudek,et al. Is confocal microscopy a valuable tool in diagnosing nodular lesions? A study of 140 cases , 2013, The British journal of dermatology.
[17] D. Sasseville,et al. Cutaneous malignant melanoma incidence and mortality trends in Canada: A comprehensive population-based study. , 2019, Journal of the American Academy of Dermatology.
[18] S. Swetter,et al. Behavioral determinants of successful early melanoma detection , 2012, Cancer.
[19] A. Halpern,et al. Patterns of detection in patients with cutaneous melanoma , 2000, Cancer.
[20] R. Wolfe,et al. Clinically amelanotic or hypomelanotic melanoma: Anatomic distribution, risk factors, and survival , 2018, Journal of American Academy of Dermatology.
[21] C. Balch,et al. Identifying early melanomas at higher risk for metastases. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] R. Scolyer,et al. Data Set for Pathology Reporting of Cutaneous Invasive Melanoma , 2013, The American journal of surgical pathology.
[23] David C Whiteman,et al. The melanomas: a synthesis of epidemiological, clinical, histopathological, genetic, and biological aspects, supporting distinct subtypes, causal pathways, and cells of origin , 2011, Pigment cell & melanoma research.
[24] J. Grob,et al. The 'ugly duckling' sign: identification of the common characteristics of nevi in an individual as a basis for melanoma screening. , 1998, Archives of dermatology.
[25] H. Karim-Kos,et al. Trends of cutaneous melanoma in The Netherlands: increasing incidence rates among all Breslow thickness categories and rising mortality rates since 1989. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.
[26] Shannon C. Trotter,et al. Skin cancer screening: recommendations for data-driven screening guidelines and a review of the US Preventive Services Task Force controversy , 2017, Melanoma management.
[27] Susan M Swetter,et al. Efficacy of Skin Self-Examination Practices for Early Melanoma Detection , 2009, Cancer Epidemiology, Biomarkers & Prevention.
[28] Paula R. Blasi,et al. Screening for Skin Cancer in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. , 2016, JAMA.
[29] B. Mcavoy,et al. Nodular melanoma. No longer as simple as ABC. , 2003, Australian family physician.
[30] Blair H. Smith,et al. Genome-wide association meta-analyses combining multiple risk phenotypes provides insights into the genetic architecture of cutaneous melanoma susceptibility , 2020, Nature Genetics.
[31] S. Gruber,et al. Is physician detection associated with thinner melanomas? , 1999, JAMA.
[32] Lin Fritschi,et al. Nodular melanoma: patients' perceptions of presenting features and implications for earlier detection. , 2003, Journal of the American Academy of Dermatology.
[33] Myles G Cockburn,et al. Increasing burden of melanoma in the United States. , 2009, The Journal of investigative dermatology.
[34] G. Giles,et al. Nodular type and older age as the most significant associations of thick melanoma in Victoria, Australia. , 2002, Archives of dermatology.
[35] R. Hofmann-Wellenhof,et al. Melanoma recognition by a deep learning convolutional neural network-Performance in different melanoma subtypes and localisations. , 2020, European journal of cancer.
[36] Rory Wolfe,et al. Rate of growth in melanomas: characteristics and associations of rapidly growing melanomas. , 2006, Archives of dermatology.
[37] P. V. van Diest,et al. Subtyping Cutaneous Melanoma Matters , 2020, JNCI cancer spectrum.
[38] W. Clark,et al. The histogenesis and biologic behavior of primary human malignant melanomas of the skin. , 1969, Cancer research.
[39] G. Argenziano,et al. Dermoscopy and in vivo confocal microscopy are complementary techniques for diagnosis of difficult amelanotic and light‐coloured skin lesions , 2016, The British journal of dermatology.
[40] B K Armstrong,et al. Melanoma of the skin. , 1984, British medical bulletin.
[41] M. Weinstock,et al. Melanoma thickness trends in the United States, 1988-2006. , 2010, The Journal of investigative dermatology.
[42] D. Kivaranovic,et al. The burden of malignant melanoma--lessons to be learned from Austria. , 2016, European journal of cancer.
[43] Donald R. Miller,et al. Total Nevi, Atypical Nevi, and Melanoma Thickness: An Analysis of 566 Patients at 2 US Centers. , 2016, JAMA dermatology.
[44] R. Marais,et al. Nodular Melanoma: A Histopathologic Entity? , 2018, Acta dermato-venereologica.
[45] K. Shannon,et al. Reappraisal of the prognostic significance of mitotic rate supports its reincorporation into the melanoma staging system , 2020, Cancer.
[46] J. Bowling,et al. Dermoscopic evaluation of nodular melanoma. , 2013, JAMA dermatology.
[47] G. Moynihan. The 3 Cs of melanoma: time for a change? , 1994, Journal of the American Academy of Dermatology.
[48] M. Weinstock,et al. Association between risk factors and detection of cutaneous melanoma in the setting of a population-based skin cancer screening , 2017, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[49] Tumaini R. Coker,et al. Screening for Skin Cancer: US Preventive Services Task Force Recommendation Statement. , 2023, JAMA.
[50] M. Weinstock,et al. The contribution of nodular subtype to melanoma mortality in the United States, 1978 to 2007. , 2012, Archives of dermatology.
[51] E. Coups,et al. Skin self-examination behaviors among individuals diagnosed with melanoma , 2016, Melanoma research.
[52] L. Akslen,et al. BRAF-V600E expression in primary nodular melanoma is associated with aggressive tumour features and reduced survival , 2016, British Journal of Cancer.
[53] P. Lorigan,et al. Survival of patients with early invasive melanoma down‐staged under the new eighth edition of the American Joint Committee on Cancer staging system , 2019, Journal of American Academy of Dermatology.
[54] D. Whiteman,et al. The Growing Burden of Invasive Melanoma: Projections of Incidence Rates and Numbers of New Cases in Six Susceptible Populations through 2031. , 2016, The Journal of investigative dermatology.
[55] S. Dalton,et al. Incidence of In Situ and Invasive Melanoma in Denmark From 1985 Through 2012: A National Database Study of 24,059 Melanoma Cases. , 2015, JAMA dermatology.
[56] R. Scolyer,et al. Melanoma Staging: American Joint Committee on Cancer (AJCC) 8th Edition and Beyond , 2018, Annals of Surgical Oncology.
[57] T. Kirchhoff,et al. Primary Melanoma Histologic Subtype: Impact on Survival and Response to Therapy , 2018, Journal of the National Cancer Institute.
[58] A. Gavin,et al. Trends in incidence of thick, thin and in situ melanoma in Europe. , 2018, European journal of cancer.
[59] Chyke A Doubeni,et al. Behavioral Counseling to Prevent Skin Cancer: US Preventive Services Task Force Recommendation Statement , 2018, JAMA.
[60] D. Polsky,et al. De Novo vs Nevus-Associated Melanomas: Differences in Associations With Prognostic Indicators and Survival. , 2016, Journal of the National Cancer Institute.
[61] V. Mar,et al. Differing trends in thickness and survival between nodular and non‐nodular primary cutaneous melanoma in Victoria, Australia , 2015, The Medical journal of Australia.
[62] H. Soyer,et al. Clinicopathological factors associated with death from thin (≤ 1·00 mm) melanoma , 2019, The British journal of dermatology.
[63] L. Palmer,et al. The association of host and genetic melanoma risk factors with Breslow thickness in the Western Australian Melanoma Health Study , 2014, The British journal of dermatology.
[64] L. Akslen,et al. High mortality due to cutaneous melanoma in Norway: a study of prognostic factors in a nationwide cancer registry , 2018, Clinical epidemiology.
[65] R. Wolfe,et al. Characteristics and associations of high-mitotic-rate melanoma. , 2014, JAMA dermatology.
[66] F. Sera,et al. Meta-analysis of risk factors for cutaneous melanoma according to anatomical site and clinico-pathological variant. , 2009, European journal of cancer.
[67] Rajiv Kumar,et al. Dysplastic vs. Common Naevus-associated vs. De novo Melanomas: An Observational Retrospective Study of 1,021 Patients. , 2018, Acta dermato-venereologica.
[68] I. Osman,et al. Superficial spreading and nodular melanoma are distinct biological entities: a challenge to the linear progression model , 2012, Melanoma research.
[69] A. Lallas,et al. European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics: Update 2022. , 2022, European journal of cancer.
[70] R. Scolyer,et al. Evolving concepts in melanoma classification and their relevance to multidisciplinary melanoma patient care , 2011, Molecular oncology.
[71] R. Braun,et al. Incidence trends and clinical–pathological characteristics of invasive cutaneous melanoma from 1980 to 2010 in the Canton of Zurich, Switzerland , 2017, Melanoma research.
[72] S. Swetter,et al. Nevus Count Associations with Thinner Nodular or Superficial Spreading Melanoma. , 2019, Acta dermato-venereologica.
[73] H. Storm,et al. Incidence and survival in patients with cutaneous melanoma by morphology, anatomical site and TNM stage: a Danish Population-based Register Study 1989-2011. , 2015, Cancer epidemiology.
[74] S. Swetter,et al. Association of Skin Examination Behaviors and Thinner Nodular vs Superficial Spreading Melanoma at Diagnosis , 2018, JAMA dermatology.
[75] A. Lallas,et al. Management Rules to Detect Melanoma , 2013, Dermatology.
[76] Michael P Schön,et al. Association of Patient Risk Factors and Frequency of Nevus-Associated Cutaneous Melanomas. , 2016, JAMA dermatology.
[77] Jeffrey E Gershenwald,et al. Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual , 2017, CA: a cancer journal for clinicians.
[78] Susan M Swetter,et al. Focus on early detection to reduce melanoma deaths. , 2015, The Journal of investigative dermatology.
[79] I. Zalaudek,et al. Distinct clinicopathological and prognostic features of thin nodular primary melanomas: an international study from 17 centers. , 2019, Journal of the National Cancer Institute.
[80] J. Kantor,et al. Routine dermatologist-performed full-body skin examination and early melanoma detection. , 2009, Archives of dermatology.
[81] Carrie D. Patnode,et al. Behavioral Counseling for Skin Cancer Prevention: Evidence Report and Systematic Review for the US Preventive Services Task Force , 2018, JAMA.
[82] C. Ingvar,et al. Invasive cutaneous malignant melanoma in Sweden, 1990–1999 , 2004, Cancer.
[83] I Zalaudek,et al. Blue‐black rule: a simple dermoscopic clue to recognize pigmented nodular melanoma , 2011, The British journal of dermatology.
[84] J. Malvehy,et al. Prognostic role of the histological subtype of melanoma on the hands and feet in Caucasians , 2017, Melanoma research.
[85] J. Malvehy,et al. High nevus counts confer a favorable prognosis in melanoma patients , 2015, International journal of cancer.
[86] D. Schadendorf,et al. Adjuvant melanoma therapy with new drugs: should physicians continue to focus on metastatic disease or use it earlier in primary melanoma? , 2018, The Lancet. Oncology.
[87] D. English,et al. Nodular melanoma: a distinct clinical entity and the largest contributor to melanoma deaths in Victoria, Australia. , 2013, Journal of the American Academy of Dermatology.
[88] D. Whiteman,et al. Anatomic site, sun exposure, and risk of cutaneous melanoma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[89] M. Zappa,et al. The thickness of melanomas has decreased in central Italy, but only for thin melanomas, while thick melanomas are as thick as in the past , 2010, Melanoma research.
[90] L. Wheless,et al. Mitotic rate is associated with positive lymph nodes in patients with thin melanomas , 2017, Journal of the American Academy of Dermatology.
[91] S. Rosso,et al. Comparison of clinicopathologic features and survival of histopathologically amelanotic and pigmented melanomas: a population-based study. , 2014, JAMA dermatology.
[92] N. Hayward,et al. Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma. , 2003, Journal of the National Cancer Institute.
[93] A. Stromberg,et al. Outcomes and prognostic factors in nodular melanomas. , 2012, Surgery.
[94] Donald R. Miller,et al. Early detection of thick melanomas in the United States: beware of the nodular subtype. , 2005, Archives of dermatology.
[95] A. Gesierich,et al. Acral lentiginous melanoma: a skin cancer with unfavourable prognostic features. A study of the German central malignant melanoma registry (CMMR) in 2050 patients , 2018, The British journal of dermatology.
[96] R. Wolfe,et al. Nodular melanoma is less likely than superficial spreading melanoma to be histologically associated with a naevus , 2017, The Medical journal of Australia.
[97] A. Lallas,et al. European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics - Update 2019. , 2020, European journal of cancer.
[98] B. Glick. Efficacy of Skin Self-Examination Practices for Early Melanoma Detection , 2011 .
[99] D. Whiteman,et al. Factors Related to Nevus-Associated Cutaneous Melanoma: A Case-Case Study. , 2018, The Journal of investigative dermatology.